Mounjaro Clinics in Pennsylvania
2 physician-supervised clinics prescribing Mounjaro for Pennsylvania residents via 2 telehealth providers. Compare consultation fees, treatment areas, and access before you enquire.
Telehealth providers serving Pennsylvania (2)
I
Consult
Telehealth
Consult Fee
Not published
Injury RecoveryWeight ManagementLongevity & NAD+
Physician-led
Send Inquiry
Free inquiry - no obligation
Consult
Both
Consult Fee
Not published
Injury RecoveryWeight ManagementMuscle & Performance
Physician-led
Send Inquiry
Free inquiry - no obligation
Mounjaro clinics in other states
About Mounjaro
Mounjaro is the brand name for tirzepatide 2.5mg-15mg weekly injection, developed by Eli Lilly and FDA-approved in 2022 for the treatment of type 2 diabetes. It is the world's first dual GIP and GLP-1 receptor agonist - meaning it activates two hormone pathways simultaneously, which produces significantly greater blood sugar control and weight loss than single-agonist GLP-1 drugs like semaglutide.
Read the full Mounjaro guide →